Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000875313 | SCV001017621 | likely benign | Marfan syndrome; Familial thoracic aortic aneurysm and aortic dissection | 2023-09-08 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV001188980 | SCV001356172 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2018-11-09 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV001193540 | SCV001362439 | likely benign | not specified | 2019-12-14 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001311860 | SCV001502200 | likely benign | not provided | 2024-07-01 | criteria provided, single submitter | clinical testing | FBN1: BP4, BP7 |
Ambry Genetics | RCV001188980 | SCV002624340 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2019-03-28 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
All of Us Research Program, |
RCV004003104 | SCV004823135 | likely benign | Marfan syndrome | 2023-12-13 | criteria provided, single submitter | clinical testing |